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Neonatal lupus erythematosus (NLE) is an antibody-
mediated disorder of infants characterized by two 
major clinical manifestations; cutaneous lupus le-
sions and congenital heart block (CHB). The disease 
is associated with placentally transferred maternal 
anti-Ro/SSA and/or LalSSB antibodies. There is a 
tendency for the same disease expression to occur 
within a sibship. To reveal a possible association of 
class II MHC genes with maternal anti-Ro/SSA auto-
inunune responses and neonatal outcomes in NLE 
with a relatively homogeneous ethnic background, 
haplotype, and allele distributions were analyzed 
based on the PCR-RFLP results in 26 Japanese anti-
RaISSA-positive mothers from three groups defined 
by neonatal outcomes. The results were as follows: 
(i) lIlaternal HLA-DR5 haplotype DRB1*1101-
H uman leukocyte antigen (HLA) class II genes are characterized by a 111.' gh degree of polymorphism and strong linkage disequilibrium between alJeles of the DR 311d DQ loci. HLA class Il molecules are known to playa key role in immune recognition of 
foreign antigens and self antigens by CD4 + T cells. Susceptibility to 
some autoimmWle diseases may be related to specific amino acid 
sequences on certain domains ofHLA class II molecules (Todd e/ nl, 
1988; Altmann el nl, 1991) . 
Neonatal Jupus erythematosus (NLE) is an 3l1tibody-mediated 
disord er characterized by 1:\"'0 major clinical manifes tations; tran-
sient cutaneous lupus lesions and congenital heart block (CHB) , 
w hic h is permanent (Watson et nl, 1984; Lee, 1993). T hese two 
findings may occur together in the same infant but more commonly 
occur independently (Watson e/ nl, 1984). Babies with NLE have 
matemal autoanti.bodies against Ro/SSA, La/SSB, or both , pas-
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DQA1 *0501-DQB1 *0301 and individual class II al-
leles making up this haplotype were significantly 
associated with neonatal cutaneous lupus but not 
CHB. Conversely, maternal HLA-DQB1*0602 carried 
on HLA-DR2 haplotypes was associated with CHB 
but not cutaneous NLE; (ii) HLA-DQAl alleles with 
glutamine at position 34 of the first domain, which 
have reportedly been associated with the autoim-
mune responses to Ro/SSA antigens in other ethnic 
groups, were increased in the mothers of infants with 
cutaneous involvement; and (iii) there was no partic-
ular class II HLA profile that distinguished the disease 
manifestations in infants. These findings suggest that 
specific maternal MHC class II genes might correlate 
with specific neonatal outcomes in NLE. ] Illvest 
Del'tnatol 108:881-885, 1997 
sively transferred through the placenta . NLE is rarely associated 
with 311tibodies to the Ul ribonucleoprotein (Provost e/ ai, 1987) . 
NLE m ay occur in siblings, w itl] a tendency fo r the same disease 
expression w ithin a sibship. 
There is now good evidence to suggest that in Caucasian and 
N o rth American Black populations, 3l1ti-Ro/ SSA-positive women 
w ho possess serologically defin ed HLA-DR3 (in linkage disequi-
librium with -DQ2) are at ri sk of giving birth to an infant with NLE 
(Lee e/ ai, 1983; W atson e/ nl, 1984; Alexander e/ ai, 1989; Watson 
e/ ai, 1992; Brucato e/ nl, 1995). M ore recent studies wi th DNA 
typing have suggested that the HLA-DR3 association with an 
autoimmune response to R o/SSA is largely explained by the 
DR3 haplotype bearing HLA-DRB1 *0301, DQA1 *0501, and 
DQB1 *0201 (Reveille e/ nl, 1991; Am ett, 1992) . It is noteworthy, 
however, tllat HLA-DR3 and -DQ2 are very rare in J apanese 
populations and have not been reported in either Jap311ese NLE 
motllers or Japanese anti-Ro/ SSA-positive SS / SLE patients 
(Kaneko e/ nl, 1992; Miyagawa e/ nl, 1992). T he different distribu-
tions of I-ILA-DR and -DQ loci reported in these studies might be 
due to differences among the ethnic groups. 
By using the polymerase chain reaction-coupled restriction frag-
ment length polymorphism metllOd, we recently showed tllat 
HLA-DQA1 and DQBl alleles possessing specific amino acid 
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Table I. Ill.A Class II Alleles in Relation t o Clinical Features and Antibody Pro files in Mothers of Infants with 
Cutaneous Involvement of NLE 
HLA Class II Allele 
Mother Age" (y) Diagnosis Anti-ENA" OfEpring' DRB1 " DQA1 * DQB1 " DPB1 ' 
S-l <1 28 Asymptomatic SSA 2S 1101' 0501 0301 0501 
1302 0102 0604 0401 
S-2 30 SLE SSA, SSB I N, IS, IN 08032 0103 0601 0501 
1302 0102 0609 0501 
S-3 32 Asymptomatic SSA, SSB lS , IN, IS 08032 0103 0601 0501 
0802 0301 0302 0501 
S-4 34 SLE SSA, SSB 3S 08032 0103 0601 0501 
1101 0501 0301 0501 
S-5 36 Asymptomatic SSA, SSB 2S 08032 0103 0601 0501 
1403 0503 0301 0501 
S-6" 38 SS SSA, SSB 2N,2S 1101 0501 0301 0501 
1406 0503 0301 0501 
S-7" 48 SLE SSA, SSB 2S 1101 0501 0301 0501 
1101 0501 0301 0501 
" Age", HLA genotyl'in g. 
II Autoantibodies against extractable nuclear antigens (ENAs) defined by immunodiffusion. 
C O utcomes of offspring include skin lesions (5) of luplis dermatitis, an d asymptomatic (N). 
" Cases reported previously (Miyagawa <I aI, 1997). 
, Alleles underlined indicate HLA-DR.Bl alleles w ith arginine at position 71, DQAl alleles with glutamine at position 34, or DQBl alleles with leucinc at position 26 of their 
respective Quteml0S[ domains. 
residues tha t are reportedly associated with anti-Ro/SSA autoanti-
body responses in other ethnic groups (Reveille et aI, 1991) were 
also found in seven J apan ese anti-Ro/SSA-positive mothers whose 
infants had NLE, suggesting shared susceptibility factors across 
racial barriers in maternal predisposition to Ro/SS A au toimmune 
responses (Mlyagawa et ai, 1997), This observation led us to 
examine a larger number of anti-Ro/SSA-positive mothers. The 
purposes of the present study w ere to investigate whether certain 
HLA class II alleles predispose to anti-Ro/SSA autoimmune re-
sponses and to find a possible association between maternal HLA 
class II alleles and neonatal outcom es in n eon atal lupus erythema-
tosus within a relatively homogeneous ethnic background, 
MATElUALS AND METHODS 
Pa·tient Population The subjects in tlus study consisted of 18 unrelated 
Japanese mothers and their infants with NLE. Eight anti-Ro/SSA-positive 
mothers with only asymptomatic infants were included as a control group. 
These mothers were documented as anti-Ro/SSA-positive before deliveries 
or in perinatal periods. Clinical find ings were previously reported for the 
mother and her two infan ts with cutaneous NLE (Miyagawa of ai, 1981), 
Diagnostic Criteria Sjogren's syndrome (SS) was diagnosed according 
to the criteria proposed by the J apanese R esearch Committee for SS 
(Homma el ai, 1986), The diagnosis of systemic lupus erythematosus (SLE) 
was made according to the criteria proposed by the American College of 
RJ,cumatology (Tan ef aI, 1982). 
Antibody Studies Precipitating antibodies to Ro/SSA, La/SSB, Ul 
ribonucleoprotein, and Sm were screened by Ouchterlony double immu-
nodiffusion against rabbit thymus (Pel-Freez, Rogers, AR) or human spleen 
(from an autopsy sou.rce) extracts. Antibody specificity was defined by the 
presence of lines of identity with reference serum. 
lILA Studies Genomic DNA was isolated from peripheral blood leuko-
cytes and typed for HLA class 1I (DRB1 , DQA1, DQB1, and DPB1) alleles 
by using ti,e polymerase chain reaction-restriction fragment length poly-
morphism method as previously described (Maeda et ai, 1989; Fukumori et 
ai, 1992; Kauesluge el aI, 1994; Senger and Golds tein, 1994) with ti,e 
addition of several endonucleases to detect the class II alleles officially 
updated by the World Health Organization Nomenclature Committee 
(Bodmer e l ai, 1995). Normal controls ofHLA typing COIlS is ted of unrelated 
race-matched subjects (Hashimoto of ai, 1994; Yasunaga ef ai, 1996). 
DRB1.-DQA1-DQBl haplotypes were assigned on the basis of known 
linkage disequilibria in Japanese (Hashimoto ct ai, 1994) along with the data 
obtained in this study of mother-infant pairs. 
Statistical Analysis Three groups of mothers with different neonatal 
outcomes and a normal control group were compared for HLA class II 
haplotype or allele freq uencies. Fisher's exact tcst was employed fo r 
statistical comparisons, The p values were corrected (Pco ,.,) for the number 
of alleles tested for each locus (DRB1 = 38, DQA1 = 14, and DQB1 = 15) 
or for the number of haplotypes found in Japanese populations (DRB1-
DQA1-DQB1 = 40) (Hashimoto ef ai, 1994; Yasunaga ef ai, 1996). 
RESULTS 
Results of clinical and serologic studies as well as class II HLA 
genotyping in anti-Ro/ SSA-positive mothers of three groups de-
fined by neonatal outcomes are listed in Tables I. II, and Ill , 
respectively, Seven mothers had 14 infants with skin lesions only 
(Table I) , 11 mothers had 12 infants with CHB (Table II) , and 8 
mothers had 16 asymptomatic inf.,nts (Table III). One mother 
(Table II, mother C-l) had 2 infants with NLE, one with CHB, 
and a second younger infant with skin lesions alone . Two mothers 
(Table II, mothers C-8 and C-l0) h ad a single infant each with 
both cutaneous and cardiac manifesta tions ofNLE. These 3 moth-
ers were included among the mothers of CHB infants for statistical 
comparison . 
DNA typing of HLA class II genes in anti-Ro/SSA-positive 
mothers showed a significant association between cutaneous N LE 
and m aternal HLA-DR5 haplotype DRB1 *1101 -DQA1 *0501-
DQB1 *030 1 and suggested the importan ce of glutamine at position 
34 of the DQA1 chain. Mothers of infan ts with CHB also differed 
significantly from the normal controls in that they showed a high 
incidence of HLA-DRB1 *0602, We were unable to show an 
association of DPB1 alleles with NLE. 
HLA Class II Asso ciations 
Increase oj DRB1 *1101-DQA1 *0501-DQB1 *0301 ;1/. Mothers oj In-
jants with Cutaneol/s NLE Among the seven anti-Ro/ SSA-positive 
Japanese mothers of infants with cutaneous lupus but without eHB 
(Tables I. IV) , four (57%) had a relatively uncommon HLA-DR5 
haplotype DRB1 *1101-DQA1 *0501-DQB1 *0301 compared with 
3% in the normal controls, yielding a highly significant increase 
(Pccrr < 0,01) , The HLA alleles DRBl *1101, DQAl *0501 , and 
DQB1 *0301 that m ake up this haplotype were also significantly 
increased (Table V). HLA-DQA1 *0501 w as in linkage disequilib-
rium with HLA-DRB1 *1101 in al.l four mothers, but the 
DQB1 *0301 allele w as more common because of its linkage 
disequilibrium with additional HLA haplotypes . The DRB1 * 
08032-DQAl *0103-DQB1 *0601 haplotype and DRB1 *08032 al-
lele were increased (p < 0,05, respectively) compared to the 
incidence in normal controls but did not significantly di.ffer after 
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Table II. HLA Class II Alleles in Relation to Clinical Features and Antibody Profiles in Mothers of Infants with CHB 
HLA class II allele 
Mother Age" (y) Diagnosis Anti-ENAb Offspring' ORBI " OQA1 ' OQBl* OPBl " 
C- l,} 25 Asymptomatic SSA lC1m, IS 0405' 0302 0401 0501 
1501 0102 0602 0501 
C-2 27 Asymptomatic SSA l CHB, lND 0901 0302 0303 0501 
1501 0102 0602 0201 
C-3 31 SLE SSA, RNP 2CHB, IN 0405 0302 0401 0501 
08032 0103 0601 0201 
C- 4 35 Asymptomatic SSA l CHB,4N 0405 0302 0401 0501 
1302 0102 0604 0401 
C-5 ,} 37 Asymptomatic SSA, SS13 1CHB,2N 08032 0103 0601 0501 
08032 0103 0601 0501 
C- 6 38 Asymptomatic SSA IND, l CHB 0405 0302 0401 0501 
0901 0302 0303 0501 
C-7 38 Asymptomatic SSA, SSE 1C1-IB 0405 0302 0401 0501 
0802 0301 0302 0501 
C- 8 42 SLE SSA lCHB/S 0405 0302 0401 0501 
1501 0102 0602 0201 
C- 9,j 45 Asymptomatic SSA 10, IN , 10ill 1501 0102 0602 0501 
1502 0103 0601 0501 
C-I 0 46 Asymptomatic SSA, SSE 2ND ... 08032 0103 0601 0501 
l CI-ill/S 1406 0503 0301 0501 
C _l1d 47 Asymptomatic SSA, SSE lFDCHB , 0405 0301 0302 0501 
l CHB, 1N 1602 0102 0602 0501 
Q b 11 e Sec corresponding' notes in Table 1. 
e O utcomes of olfspring include C1-1B, skiu lesions (S) oflupus dermatitis, intrauterine fctal death from unknown cause (D) or rrom CHB (FOeHll), asymptomatic (N) . and no 
data available (ND) . 
correction of P values (Tables IV, V). AU seven mothers h ad one 
or two of these HLA class II DRB1-DQA1-DQB1 h aplotypes. 
The frequency zero of DQA 1 *0302 ill tlus group reached 
statis tical significance (Peorr < 0.05) compared to that in norma] 
control subjec ts . 
ItlCrease oJ HLA -DQB1 *0602 ill Motllers oj Ilifilllts with C HB Ma-
ternal DQB1 "0602, which was carried on HLA-DR2 haplotypes 
including DRB1 *1501 and DRB1 *1602, showed a significantly 
increased incide nce (Peon' < 0.05) in 11 mothers of CHB inGlnts 
compared with that in the normal control population (Tables II, 
V). The haplotype DRBI *1501-DQAl*0102-DQB1*0602 as weU 
as individual alleles DRB1 *1501, DRBl *0405, and DQA1 *0102 
sho-wed an increase but did not significantly diffe r w hen the p value 
was corrected for the number of comparisons (Tables IV, V). 
There Wns No Pnrtiwlnr HLA Clnss II Profile ill A llti-RoISSA-Positille 
1I1others witiJollt NLE No significant increase in HLA class II 
haplotype or allele frequencies was fo und in eight anti-Ro/SSA-
positive mothe rs who had only clinically nonnal infants w h en 
compared with the norm al controls (Tables IV, V); h owever, 
three of eight mothers in tlus group (Table III) demonstrated t\'Vo 
h eterozygous DRB1-DQA1-DQBl haplotypes, both of w hich 
were identical with those of the mothers w ith affected infants 
(patients N - l , N-6, and N-8 versus S-4, C-l, C - 7, respectively). 
COlllpnrisoll oj the GrollpS oj A liti-RoISSA-Positive 1I1o/Ilers wilh 
DiD'erelll Neollntal Outcollles Increased fi'equ en cies of HLA-
DRB1 *1101-DQAl *OSOl-DQBl *0301 and individual class II al -
le les making up this haplotype were o bserved in m ochel'S of infants 
with cutaneous involvem ent (p < O. as, fo r each h aplotype or 
Tablem. HLA Class II Alleles in Relation to Clinical Features and Antibody Profiles in Mothers of Asymptonlic hlfants 
HLA class U allele 
Mother Age" (y) Diagnosis Anti-ENA" Offspring' ORB1 ' DQAI ' DQE1 * OPEl ' 
N -l 27 SLE SSA, SSE IN 08032" 0103 0601 0501 
1101 0501 0301 0501 
N-2 30 Asymptomatic SSA 2N 08032 0103 0601 0501 
1405 0104 05031 0501 
N-3 30 Asymptomatic SSA 3N 0410 0302 0402 0201 
1302 010Z 0604 0501 
N - 4 31 SLE SSA 2D. IN 0901 0302 0303 0501 
1202 0601 0301 0501 
N -5 34 SS SSA ZN 0901 0302 0303 0501 
120Z 0601. 0301 0402 
N-6 35 SLE SSA lN 1501 0102 0602 0501 
0405 0302 0401 0201 
N -7 37 SLE SSA 4N 0901 0302 0303 0501 
0901 0302 0303 0202 
N-8 39 SS SSA 2N 0405 0302 0401 0201 
0802 0301 0302 0501 
a b t! Sec corresponding notes in Table I . 
& Outcomes of o lf.sp ring include asymptomati c (N) :Iud intrauterine fetal death from Unkll ()'\vn cause or death fronl complex cardi:\c defc.ct.~ after birth (D). 
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Table IV. Frequencies of Selected HLA-DRB1-DQA1-DQBl Haplotypes in Anti-Ro/SSA-Positive Mothers from Three 
Groups Defined by Neonatal Outcomes 
No. Mothcrs of Childrcn with Neonata'l Outcomes' 
Class II HLA Cutaneous CHB No Symptoms Normal 
Haplotype" NLE (%) ("!o) (,X» Control (%) 
DR.B1 *-DQA1 *-DQB1 * (n = 7)" (n = 11) (n = 8) (11 = 525) 
1501-0102-0602 0 4 (36.4)' 1 (12.5) 11.6 
0405-0302-0401 0 6 (54.5) 2 (25.0) 26.5 
1101-0501-0301 4 (57.1)' 0 1 (12.5) 3.2 
OB032-0103-0601 4 (57.1),' 3 (27 .3) 2 (25.0) 17.7 
0901-0302-0303 0 2 (18.2) 3 (37.5) 29 .5 
"Other HLA class 11 haplotypes. ORB1 ' lS02-0QA 1 ' 01 02-0QB1 ' 0601 , DRB1 ' 1602-DQA 1' 01 02-DQBl ' 0602. DIUlI ' 040S-0QA 1' 0301-0QB I' 0302. OIUlI ' 1302-
OQA 1' 0'1 02-0QB1'06, D1Ull ' 14-DQA l ' OS03-0QBl ' 0301 . and ORB l ' 0802-DQA l '0301-DQB1 ' 0302. that were found in one or two mothers of children w ith NLE could 
not be statisticaUy evaluated because of low frequencies (about 5%1 or less) ,l111ong Japanese populations. 
/, n is the number of patients and controls examined. 
r p values were determined by Fisher's exact tcst comparing percentages of patients and contro ls positive for a haplotype. The uncorrected p vaJue is listed when it was less [han 
0.05. 
d P < 0.05. 
e p < 0.00 t when [he correc[cd p value was less [han 0.05. 
allele) compared to those in mothers of CHB infants. Conversely, 
HLA-DRBl *0405-DQAl '0302-DQBl '0401, individual alleles 
making up this haplotype, and DQBl '0602 were increased in 
mothers of CHB infants compared to those in mothers of infants 
with cutaneOllS NLE (p < 0.05, respectively). HLA-DQAl ·0302 
was decreased in the group of mothers of infants with cutaneous 
NLE compared to two other groups (p < 0.05, respectively). These 
differences, however, failed to reach significance after correction of 
p values . No other HLA class II alle le or haplotype frequency 
differed significantly among the three groups of mothers. 
No HLA C lass II Gene Distillguished the Disease Mallifestatiolls of NLE 
i/l. the Qffsprillg Class II genotyping was performed in seven of 15 
children who had had cutaneous NLE in their infancy, nine of 12 
children with ClIB, and their five asymptomatic siblings. There 
was no class II HLA profile that could distinguish the disease 
manifestations of NLE. We observed two pairs of HLA-DRB1-
DQA1-DQBl identical siblings; only one of whom had CHB' and 
the other was healthy. Statistical analysis was not done because 16 
of 21 children examined were siblings. 
Table V. Frequencies of Selected HLA-DR and -DQ 
Alleles in Anti-Ro/SSA-Positive Mothers from Three 
Groups Defined by Neonatal Outcomes 
Allele 
DRB1 *1501 
0405 
lt01 
08032 
0901 
DQA1 ' 0102 
0302 
0501 
DQB1'0301 
0303 
0401 
0602 
No. Mothers of Children 
with Neonatal Outcomes 
Cutaneous CHB No Symptoms 
NLE(%) (%) ('Yo) 
(n = 7) (n = 11) (11 = B) 
0 4 (36.4)" 1 (12.5) 
0 7 (63.6), 2 (25.0) 
4 (57.1)" 0 1 (12.5) 
4 (57.1)" 3 (27.3) 2 (25.0) 
0 2 (18.2) 3 (37.5) 
2 (28.6) 6 (54.5)" 2 (25.0) 
0' 7 (63. 6) 6 (75.0) 
4 (57.1)" 0 1 (12.5) 
5 (71.4)'" 1 (9.1) 3 (37.5) 
0 2 (18.2) 3 (37.5) 
0 6 (54.5) 2 (25.0) 
0 5 (45.5),' 1 (12.5) 
.. For 11 and p values. sec n otes in Table IV. 
• P < 0.05. 
' I' < 0.01. 
(I P < 0.001 when corrected p value was < 0.05. 
r- p < 0.01 when corrected p value was < 0.05. 
Normal 
Control (%) 
(11 = 525) 
11.6 
26.5 
3.2 
17.7 
29.5 
24.2 
56.8 
11.1 
19.2 
30.3 
26.5 
11.8 
Importance of Maternal Class II HLA-DR and -DQ Poly-
morphic Amino Acid Residues in Cutaneous NLE ALI seven 
mothers of i.nfants with cutaneOllS NLE had at least one DQAl 
allele (DQA1 *0102, *0103, *0501, or *0503) with glntamine at 
position 34 of the first domain (Marsh and Bodmer, 1995). The 
frequency of HLA-DQAl alleles beari.ng the glutamine residue at 
position 34 (DQAI_Gln34 ) was 13/14 (93%) in the seven mothers, 
and significantly higher (p < 0.001) compared to 44% of normal 
controls (Hashimoto et aI, 1994). Four of the seven mothers had 
leucine at position 26 (DQB1 -Leu26) of the first domain of the 
DQBl '0602 , *0604, *0302, or *0303 chain (Marsh and Bodmer, 
1995) . The allele frequency 5/14 (36%) of DQBI_Leu26 did not 
differ from that of control subjects. As shown in Table I, all seven 
mothers had two or three DQ alleles with DQA1_GLn34 andlor 
DQBI-Leu26 , which have been associated with the autoimmune 
responses to Ro/SSA antigens (Revei lle et ai, 1991). 
Allele frequencies ofDQAl-Gln34 and DQBI_Leu26 in the other 
mother groups were not higher than those in the normal popula-
tions; but all 26 anti - Ro/SSA-positive mothers had at least one 
allele of DQAI_Gln3 4 andlor DQBI_Leu26 (Tables II, III). 
All 21 infants examined inherited at least one DQ chain contain-
ing the relevant amino acid residues primarily from tile mother, but 
also from the father in some cases. 
It is of great interest that HLA-DRB1 *1101 and *08032 share 
many amino acid sequences of the hypervariable regions of the 
DRBl chain that are known to pLay a key role in immune 
recognition of antigenic peptides (Brown et aI, 1993). The poly-
morphic amino acid residues ofHLA-DRBl *1101 di.ffer from those 
of DRJ31 *08032 only at positions 13, 57, 58, 67, and 74; Ser13 , 
ASpS7, Glu s8 , Phe67 , and Ala74 for DRBl *1101, and Gli 3 , SerS7 , 
Alass , neG7 , and Leu 7 " for DR13i*08032, respectively (Marsh and 
Bodmer, 1995). 
All 26 anti-Ro/SSA-positive mothers except 1 (patient C-9) had 
HLA-DRBl a11e les with arginine at position 71 of the DR131 chain , 
which has been associated with susceptibility to rheumatoid arthritis 
(Todd e/ aI, 1988). 
DISCUSSION 
Th.is study demonstrates that maternal class II major h.istocompat-
ibility complex genes are strongly associated with expression of 
NLE. Although the number of mothers studied was sma11 and 
additional studies are warranted, a high.ly significant association of 
cutaneous NLE (four of seven, 57%), but not CHB, with maternal 
lILA-DRS haplotype bearing HLA-DRB1 *1101, DQAl *0501 , 
and DQBl '0301 was found i.n comparison to that (3%) in the 
race-matched normal individuals. In contrast, CHB was found to be 
associated with maternal HLA-DQ131 *0602, which was carried ou 
VO L. 108, NO. (, JUNE 1997 
HLA-DR2 haplotypes. Although the comparison failed to reach 
significance after correction of p values, the HLA-DR8 haplotype 
DRB 1 *08032-DQAl "0103-DQB1 "0601 was increased in NLE 
mothers as a whole, occurring in seven of18 (39%) overall, in four 
of seven (57°;'») of mothers of infants with cutaneous NLE, and in 
three of 11 (27%) of mothers with Cr-IB inf:1nts compared to 18% 
in nonnal controls. All mothers of infants with skin lesions had one 
or two of the class II haplo types DRB1 *1101-DQA1 "0501 -
DQBl · 0301 and DRB1 *08032-DQAl "' 0103-DQB1 *060t . Note-
worthy is the similarity of the amino acid sequencies of the 
polymorphic regions of HLA-DRBl *1101 and DRB1 *08032 mol-
ecules. Since the polymorphic amino acids are predicted to map to the 
groove of the proposed model for major histocompatibility complex 
molecules (Brown el Ill, 1993), they could be essential for peptide 
presentation to T cells in autoinunune responses to Ro/SSA antigens. 
In addition, this study con£inlled and extended our earlier data 
(Miyagawa elll/, 1997) showing that all anti-Ro/SSA-positive mothers 
had HLA-DQAl alleles with glutamine at position 34 andlor DQB1 
alleles with leucine at position 26 of their respective outermost 
domains, previously associated widl anti-Ro/SSA autoantibody re-
sponses in Caucasian and Black populations (Reveille el Ill, 1991). 
Mothers ofi11.fants with cutaneous lupus but without CH8 were more 
likely to have both of their DQA1 alleles containing glutamine at 
position 34 (DQA1_Gln34 positive allele frequency, 13/14) . T hus, 
dlere were sinlilarities among different racial groups widl regard to 
these alleles and anti-Ro/SSA autoreactivity. 
It is known that the majority of mothers of NLE in[.111ts possess 
the serologically defined HLA-DR3 phenotype, especially among 
North American and Western European Caucasians (Lee et Ill , 
1983; Watson et Ill, 1984; Alexander el Ill, 1989; Watson et Ill, 1992; 
Brucato e/ Ill, 1995). There is no simple re lationship, however, 
among the presence of maternal HLA-DR3, the presence of 
anti-Ro/SSA antibodies, and the development of the NLE syn-
drome. In addition, no serologically defined HLA phenotype in the 
infant has been associated with expression of N LE (Lee el Ill, 1983; 
Watson et Ill , 1984; Alexander et Ill, 1989; Watson cl ai, 1992). 
Thus, although genetically determined autoantibody production 
occurs in the mother, tissue injury may depend on other factor(s) 
that are unknown at present. 
Little has been reported about NLE in non-Caucasians . Kaneko 
et al (1992) reported clinical features, autoantibodies, serologically 
defined HLA-A, -8, -C, and -DR specificities among J apanese 
mothers and in[.1nts with NLE. Of the few that were HLA typed, 
40% of the NLE infants and 8% of the controls had HLA-DR12 
(p < 0.005). No such associations were found in the mothers. 
Given that it is the mother who actually produces autoantibodies, 
w hich are then passed across the placenta, the significance of this 
findin g is unclear. 
At present, which class II locus is most important in susceptibility 
to NLE is not clear. One way to further address tlus question is to 
examine HLA associations in different etlmic groups in which 
linkage disequilibrium among HLA-DR and -DQ alleles may differ, 
allowing researchers to specifically identify candidate genes. 
Our report describes a difference in the immunogenetic back-
ground among anti-Ro/SSA-positive mothers according to neona-
tal outcomes. HLA class 11 genes are polymorphic in the human 
population, and diH'erent types selectively bind to diiferent sets of 
pep tides (Rudensky et Ill, 1991; Hunt e/ Ill, 1992; Clucz elll /, 1993) . 
In the pathogenesis of NLE, although little is known about the 
precise mechatusm, it is possible dlat matemal HLA polymorplusm 
is responsible for variations in the anti-Ro/SSA autoimmune 
responses and contributes to v3l;ations in disease expression in 
neonates. 
We tltallk Drs. Kalsllshi Tok llllaga (Ullillersil), oITok)'o) olld Tos l,ihiko Kallcshigc 
(Shio,wgi Biollledical Labora,urics)Ior crilical disCllssioll. T his II'ork ",as sll)!)!"rt . d ill 
part by Gralll 06670876 FOIII Ihe Millislr), of Edllcatioll , Sci.llce olld C llltllre oI 
Japan aud n gralltfrolllJapoHcse Medical ltf/cHIICI1 'S AssadatilHl. 
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